Phosphorylation of Enteroviral 2apro at Ser/Thr125 Benefits Its Proteolytic Activity and Viral Pathogenesis.
Yuya Wang,Wenjia Zou,Yan Niu,Sanyuan Wang,Bangtao Chen,Rui Xiong,Peng Zhang,Zhijun Luo,Yong Wu,Changfa Fan,Zhaohua Zhong,Ping Xu,Yihong Peng
DOI: https://doi.org/10.1002/jmv.28400
IF: 20.693
2022-01-01
Journal of Medical Virology
Abstract:Enteroviral 2A proteinase (2A(pro)), a well-established and important viral functional protein, plays a key role in shutting down cellular cap-dependent translation, mainly via its proteolytic activity, and creating optimal conditions for Enterovirus survival. Accumulated data show that viruses take advantage of various signaling cascades for their life cycle; studies performed by us and others have demonstrated that the extracellular signal-regulated kinase (ERK) pathway is essential for enterovirus A71 (EV-A71) and other viruses replication. We recently showed that ERK1/2 is required for the proteolytic activity of viral 2A(pro); however, the mechanism underlying the regulation of 2A(pro) remains unknown. Here, we demonstrated that the 125th residue Ser125 of EV-A71 2A(pro) or Thr125 of coxsackievirus B3 2A(pro), which is highly conserved in the Enterovirus, was phosphorylated by ERK1/2. Importantly, 2A(pro) with phosphor-Ser/Thr125 had much stronger proteolytic activity toward eukaryotic initiation factor 4GI and rendered the virus more efficient for multiplication and pathogenesis in hSCARB2 knock-in mice than that in nonphospho-Ser/Thr125A (S/T125A) mutants. Notably, phosphorylation-mimic mutations caused deleterious changes in 2A(pro) catalytic function (S/T125D/E) and in viral propagation (S125D). Crystal structure simulation analysis showed that Ser125 phosphorylation in EV-A71 2A(pro) enabled catalytic Cys to adopt an optimal conformation in the catalytic triad His-Asp-Cys, which enhances 2A(pro) proteolysis. Therefore, we are the first to report Ser/Thr125 phosphorylation of 2A(pro) increases enteroviral adaptation to the host to ensure enteroviral multiplication, causing pathogenicity. Additionally, weakened viruses containing a S/T125A mutation could be a general strategy to develop attenuated Enterovirus vaccines.